This site is intended for healthcare professionals only
LoginRegister
Lupin Secures USFDA Nod for Epilepsy Drug Brivaracetam in USLupin Launches Epilepsy, Migraine Drug Topiramate XR in US, Targets USD 164 Million Market
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchShilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine Patch
Ciplas Lanreotide Supply Partners Greece Plant Gets USFDA OAI StatusGST Department Launches Search, Inspection at Cipla's Maharashtra Facilities
Shukra Pharma to Invest Rs 600 Cr in Greater Noida Medical Device Park, Enters Surgical Robotics, Cancer Therapy TechShukra Pharma to Invest Rs 600 Cr in Greater Noida Medical Device Park, Enters Surgical Robotics,...
From Allergy Pills to PPIs: MPs Flag Massive Overpricing of Medicines, Seek Pricing ReformsFrom Allergy Pills to PPIs: MPs Flag Massive Overpricing of Medicines, Seek Pricing Reforms
Alembic Pharmas Karakhadi Injectable Facility USFDA InspectionAlembic Pharma Gets USFDA Final Approval for Parkinson's Drug Stalevo Generic
Zydus Settles Mirabegron Patent Dispute With Astellas for USD 120 MillionUSFDA Grants Orphan Drug Status to Zydus' Desidustat for Sickle Cell Disease
Gland Pharma Appoints Dr Jitendra Gangwal as Vice PresidentGland Pharma Gets USFDA Nod for Zoledronic Acid Injection for Cancer-Related Bone Disorders
Sun Pharma to Invest Rs 500 Cr in Assam Manufacturing Plant, 500+ Jobs ExpectedSun Pharma to Invest Rs 500 Cr in Assam Manufacturing Plant, 500+ Jobs Expected
Mankind Pharma Gets Relief as CGST Appellate Authority Drops Rs 1.02 Cr PenaltyMankind Pharma Reports 11.5% Revenue Growth in Q3 FY26
States Cannot Prescribe Additional Eligibility for Drug Inspector Posts Beyond Central Law: SCStates Cannot Prescribe Additional Eligibility for Drug Inspector Posts Beyond Central Law: SC
medicinesNavi Mumbai Airport May Join Cochin, Thiruvananthapuram as Drug Import Gateway
X